Julie Rubinstein Adaptive Biotechnologies Corp (ADPT) insider trading activity
Julie Rubinstein is President and COO of Adaptive Biotechnologies Corp. Currently has a direct ownership of 588,249 shares of ADPT, which is worth approximately $6.26 Million. The most recent transaction as insider was on Dec 22, 2020, when has been sold 15,000 shares (Common Stock) at a price of $63.99 per share, resulting in proceeds of $959,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
588K
0%
3M change
24.43%
12M change
Total Value Held
$6.26 Million
JULIE RUBINSTEIN Transaction History
JR
Julie Rubinstein
President and COO
Seattle, WA